ePrints

Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories

Lookup NU author(s): Dr John Perry

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

When evaluated in six clinical laboratories from six countries with 1,174 fresh isolates, including 715 Candida glabrata and 459 non-C. glabrata strains, GLABRATA RTT (Fumouze Diagnostics, Levallois Perret, France) yielded an overall sensitivity and an overall specificity of 95.8 and 98.9%, respectively. The results were consistent from one laboratory to another. The five false-positive results corresponded to C. parapsilosis (n = 2), C. tropicalis, C. guilliermondii, and C. lusitaniae. GLABRATA RTT allows a rapid, cost-effective, and reliable presumptive identification of C. glabrata.

Publication metadata

Author(s): Freydiere AM, Perry JD, Faure O, Willinger B, Tortorano AM, Nicholson A, Peman J, Verweij PE

Publication type: Article

Publication status: Published

Journal: Journal of Clinical Microbiology

Year: 2004

Volume: 42

Issue: 10

Pages: 4870-4872

ISSN (print): 0095-1137

ISSN (electronic): 1098-660X

Publisher: American Society of Microbiology

URL: http://dx.doi.org/10.1128/JCM.42.10.4870-4872.2004

DOI: 10.1128/JCM.42.10.4870-4872.2004

Altmetrics

Share